Why should you keep an eye on InVivo Therapeutics Holdings Corp (NVIV)?

InVivo Therapeutics Holdings Corp (NASDAQ: NVIV) is -56.07% lower on its value in year-to-date trading and has touched a low of $0.22 and a high of $2.40 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The NVIV stock was last observed hovering at around $0.49 in the last trading session, with the day’s loss setting it -0.17%.

Currently trading at $0.32, the stock is -47.00% and -53.77% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.71 million and changing -34.28% at the moment leaves the stock -69.59% off its SMA200. NVIV registered -86.41% loss for a year compared to 6-month loss of -75.70%. The firm has a 200-day simple moving average (SMA200) of $0.81.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

The stock witnessed a -58.88% gain in the last 1 month and extending the period to 3 months gives it a -63.35%, and is 44.46% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 68.35% over the week and 28.92% over the month.

Distance from 52-week low is 44.46% and -86.62% from its 52-week high. The company has generated returns on investments over the last 12 months (-104.59%).

InVivo Therapeutics Holdings Corp quarterly earnings per share for the current quarter are estimated at $0.

InVivo Therapeutics Holdings Corp (NVIV) Top Institutional Holders

15 institutions hold shares in InVivo Therapeutics Holdings Corp (NVIV), with institutional investors hold 3.44% of the company’s shares. The shares outstanding are 3.11M, and float is at 3.10M with Short Float at 0.57%. Institutions hold 3.44% of the Float.

The top institutional shareholder in the company is Blackrock Inc. with over 34714.0 shares valued at $46863.0. The investor’s holdings represent 1.12% of the NVIV Shares outstanding. As of Jun 29, 2023, the second largest holder is Vanguard Group Inc with 26246.0 shares valued at $35432.0 to account for 0.85% of the shares outstanding. The other top investors are Renaissance Technologies, LLC which holds 17266.0 shares representing 0.56% and valued at over $23309.0, while Geode Capital Management, LLC holds 0.36% of the shares totaling 11169.0 with a market value of $15078.0.

InVivo Therapeutics Holdings Corp (NVIV) Insider Activity

A total of 0 insider transactions have happened at InVivo Therapeutics Holdings Corp (NVIV) in the last six months, with sales accounting for 0 and purchases happening 0 times.